ライフサイエンスコーパス: mortality rate

1 per 1,000 people) and performance (neonatal mortality rate).

2 t dialysis treatment in a state with a lower mortality rate.

3 organ transplantation and decreased waitlist mortality rate.

4 (HEHE) is a rare vascular tumor with a high mortality rate.

5 s, but this complex procedure carries a high mortality rate.

6 reatment limitation and its influence on ICU mortality rate.

7 The syndrome has a high mortality rate.

8 roductive decline and suffered from a higher mortality rate.

9 y September 2021, which is 29% of the annual mortality rate.

10 ia was associated with an over 2-fold higher mortality rate.

11 athogen responsible for infections with high mortality rate.

12 ure studies should examine the postdischarge mortality rate.

13 symptomatic at diagnosis, but RCC has a high mortality rate.

14 pitalization and were associated with 50% of mortality rate.

15 ries were therefore associated with a higher mortality rate.

16 n and its influence on severity-adjusted ICU mortality rate.

17 most probably affects the severity-adjusted mortality rate.

18 ntly untreatable form of melanoma with a 50% mortality rate.

19 ain clinical features associated with a high-mortality rate.

20 an obstructive jaundice phenotype with lower mortality rates.

21 is still associated with high morbidity and mortality rates.

22 not notably affect kidney yield or waitlist mortality rates.

23 ns and is associated with high morbidity and mortality rates.

24 e turnover time of the carbon, and thus tree mortality rates.

25 modelling was used to estimate age-specific mortality rates.

26 ncephalitis in humans, leading to 40 to 100% mortality rates.

27 to model transmission dynamics and estimate mortality rates.

28 eaths per year, which outpaces global cancer mortality rates.

29 across geographic regions, and estimation of mortality rates.

30 p = 0.054) despite similar CRRT duration and mortality rates.

31 Papanicolaou testing, have greatly improved mortality rates.

32 cause human cerebral malaria (HCM) with high mortality rates.

33 There were no differences in 28- or 90-day mortality rates.

34 2030 (95% PI 7,803-8,169), assuming current mortality rates.

35 ure risk may be driving higher infection and mortality rates.

36 egion may be associated with higher maternal mortality rates.

37 fic risk factors or only predict in-hospital mortality rates.

38 community-acquired pneumonia leading to high mortality rates.

39 and no significant changes in readmission or mortality rates.

40 2.3% versus 2.6%, respectively; age-adjusted mortality rate 1.67 to 1.05 versus 1.35 to 0.80 per 100

41 % had a qSOFA score less than or equal to 1 (mortality rate, 17.3%; 95% CI, 15.9-18.7), whereas in pu

42 ay mortality rate (5% versus 3%), and 1-year mortality rate (18% versus 12%).

43 stability with acute kidney failure and high mortality rate (20%).

44 in positive group; P = .008), a lower 30-day mortality rate (3.8% vs 23.8% in positive group; P = .00

45 quartile 1 versus 4, 21% versus 17%), 30-day mortality rate (5% versus 3%), and 1-year mortality rate

46 95% confidence interval [CI], .187-.643) and mortality rate (6% vs 28%; P = .001; OR = 0.215; 95% CI,

47 Further, the high-risk group had a mortality rate 60 times higher than the low-risk group (

48 o significant at the region level (Northeast mortality rate 7.2 per 1000 operations vs Southeast 7.4;

49 S. feltiae-SF-MOR9 caused the highest larval mortality rate (80%) at 50 infective juveniles (IJs) cm(

50 hock is the most common cause of death, with mortality rates above 40%.

51 In 2020, the estimated cervical cancer mortality rate across all 78 LMICs was 13.2 (range 12.9-

52 of compromised oral health correlate with AD mortality rates, AD prevalence and SCD prevalence.

53 correlations between states' age-adjusted AD mortality rates, AD prevalence, subjective cognitive dec

54 iagnosis codes than non-CAHs, and short-term mortality rates adjusted for preexisting conditions but

55 The 30-day mortality rate after major amputation was 6.5% overall,

56 Thirty day mortality rates after AMI were higher among patients at

57 changes in valve replacement and in-hospital mortality rates after the public reporting initiation in

58 creased replication and higher morbidity and mortality rates along with extended tissue tropism seen

59 All AMI risk-adjusted mortality rates also declined from 2006 to 2017 with 30-

60 The mortality rate among patients with NASH is substantially

61 The mortality rate among the 835 participants who had initia

62 Annual mortality rates among breast cancer patients were signif

63 available widely, could substantially reduce mortality rates among human immunodeficiency virus-infec

64 atient stratification contribute to the high mortality rates among septic patients, despite new antim

65 Sepsis consequently has a high mortality rate and a high rate of complications for surv

66 The mortality rate and viral titer in the brains of mice ino

67 1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ suppor

68 ontributor for neonatal and under-five years mortality rates and also accounts for a short- and long-

69 This study compared mortality rates and decline in life expectancy of Irania

70 that lightning also influences savanna tree mortality rates and ecosystem processes.

71 Sex-specific mortality rates and rate differences were determined usi

72 individuals can hinder direct comparisons of mortality rates and the underlying levels of transmissio

73 y been demonstrated between pathogen-induced mortality rates and transmission rates.

74 est the importance of examining age-specific mortality rates and underscores how age standardization

75 comes (institutional stillbirth and neonatal mortality rate), and quality of intrapartum care before

76 nd mortality ratio, cumulative incidence and mortality rate, and average age at diagnosis.

77 creased severity of wilt symptoms, decreased mortality rate, and impaired systemic colonization compa

78 Hazard ratios (HRs), mortality rates, and 95% CIs were estimated using cubic

79 volumes of PAEE are associated with reduced mortality rates, and achieving the same volume through h

80 al influenza in terms of hospitalization and mortality rates, and clinical severity was similar to th

81 onia, median ICU stay, median hospital stay, mortality rates, and ICU and hospital costs were extract

82 ng environment directly influences birth and mortality rates, and thus population growth rates.

83 Mortality rates are as high as 90% due to limited treatm

84 Cholangiocarcinoma (CCA) mortality rates are increasing as a result of rising inc

85 Conifer mortality rates are increasing in western North America,

86 Swedish mortality rates are intermediate between rates for Europ

87 e the availability of antifungal treatments, mortality rates are still unacceptably high and drug res

88 With these mortality rates as reference values the analysis reveale

89 es, a significant linear regression of total mortality rate (as well as PCa specific mortality rate)

90 within the medical community due to the high mortality rate associated with these difficult-to-treat

91 anticoagulants and antiplatelet agents, the mortality rate associated with these diseases remains hi

92 Due to the high morbidity and mortality rates associated with CCHFV infection, there i

93 Initial mortality rates associated with ECMO for ARDS in COVID-1

94 In the general population, the mortality rates associated with more mental health probl

95 armeniaca) fruits on soil surface with high mortality rate at 50 and 100 IJs cm(-2).

96 All-cause mortality rates at 30, 90, and 365 days were significant

97 Outcomes were in-hospital mortality, mortality rates based on insurance type, and hospital le

98 We examined CVD mortality rates between 2007 and 2017 among all New York

99 critical for improving patient survival and mortality rates, but most diagnostics on solid tumors re

100 population dynamics by influencing birth and mortality rates, but understanding demographic structure

101 tion from the UK-based OpenSAFELY study with mortality rates by age and ethnicity across US states.

102 o examine variation in age-specific COVID-19 mortality rates by racial/ethnicity and to calculate the

103 g-computation was used to estimate adjusted mortality rates by sex and age.

104 Our study is limited by the low mortality rate, by the lack of blinding in the 'subjecti

105 Population estimates used as denominators in mortality rate calculations for infants were based on Na

106 In simulations with a constant background mortality rate, carbon turnover time decreased by 2.1% a

107 It is associated with high mortality rates, comparable to decompensated HF, and a m

108 Females had a higher 10-year mortality rate compared with males (32.8% vs. 24.7%; log

109 x damage marker) in plasma have an increased mortality rate compared with patients with lower levels.

110 tion of the world's population and have high mortality rates compared with group C.

111 ive malignancy with its global incidence and mortality rate continuing to rise, although early detect

112 AD mortality rates correlate with dental visits (r = - 0.50

113 le peak age, with an increasing amplitude of mortality rate curves from one birth-year cohort to the

114 or a youthward shift in the peak age of the mortality rate curves.

115 ized beneficiaries, the risk-adjusted 30-day mortality rates declined from 10.3% (95% CI, 10.22%-10.3

116 or AMI and HF, admissions, readmissions, and mortality rates declined over this period.

117 The age-adjusted mortality rate decreased from 1.37 to 0.83 per 100 000.

118 winning program was established in 2003, the mortality rate decreased from 38% to 5% (P < 0.0001), an

119 s have been documented and include decreased mortality rates, decreased health care delivery costs, a

120 This excessive mortality rate demonstrates a high overall injury burden

121 a close interplay with SARS-CoV and COVID-19 mortality rates, despite a current lack of research dire

122 Ovarian cancer (OC) incidence and mortality rates differ between racial groups.

123 ill patients included in these analyses, the mortality rate does not appear excessive.

124 g to health care workers because of its high mortality rate, due primarily to its antifungal resistan

125 t could significantly increase morbidity and mortality rates during extreme heat events.

126 Overall, species-specific mortality rates during the drought ranged from 0% to 34%

127 odialysis population when compared with mean mortality rates during the same 12-week period in 2015-2

128 However, its high mortality rate emphasizes its importance.

129 use it causes severe disease that has a high mortality rate, epidemic potential, and no medical count

130 fferential privacy will more strongly affect mortality rate estimates for non-Hispanic blacks and His

131 M) cutaneous squamous cell carcinoma (cSCC); mortality rates exceed 70% in patients with distant meta

132 Despite multiple reports of mortality rates exceeding 50% among critically ill adult

133 The annual mortality rate following major amputation was 22.8% in t

134 The average mortality rate for definite anaphylaxis, from 2004 to 20

135 We find larger changes in estimated mortality rates for areas with lower levels of urbanizat

136 Strikingly, reported mortality rates for CCHF are extremely variable, ranging

137 As mortality rates for high-risk cancer surgery have improv

138 eceased donor transplant rates, and waitlist mortality rates for January 1, 2016, to March 31, 2019.

139 Contemporary 6-month mortality rates for Medicare fee-for-service beneficiari

140 treatments, significant morbidity, and high mortality rates for patients with neurological diseases,

141 ents without organ dysfunction is excellent, mortality rates for patients with organ dysfunction may

142 to released data by studying estimates of US mortality rates for the overall population and three maj

143 nts died during the study period with higher mortality rates for the patients in the high MELD-Na gro

144 c group now permits analysis of age-specific mortality rates for these groups and the non-Hispanic As

145 Lightning Network and historical total tree mortality rates for this site, we conclude that lightnin

146 atory lung disease with a high morbidity and mortality rate, for which no pharmacologic treatment is

147 Florida's postreform monthly mortality rates-for drug-involved deaths, motor vehicle

148 Increased mortality rates from infectious diseases is a growing pu

149 have demonstrated state-wide variability in mortality rates from liver disease (cirrhosis + hepatoce

150 a-analysis; population numbers and all-cause mortality rates from the Human Mortality Database for th

151 Adjusted mortality rates from the model without HCC were not sign

152 Since 2011, the 30-day mortality rate has decreased (7.2% to 2.5%), stroke has

153 Increasing mortality rates have been reported for CAHs relative to

154 Measles incidence and mortality rates have significantly decreased since vacci

155 hronic ethanol consumption induced increased mortality rates, higher Aspergillus fumigatus burden and

156 overall survival, with a 2-fold decrease in mortality rate (HR, 0.50; 95% CI, 0.27 to 0.90), were ob

157 quiring two treatments (ii) complication and mortality rates (iii) local and distant recurrence (LR),

158 If mortality rates improve at the rate seen over recent yea

159 s that, collectively, contribute to the high mortality rate in affected individuals.

160 cations are central determinants of the high mortality rate in COVID-19, strategies to prevent thromb

161 is associated with severe illness and a high mortality rate in lung transplant recipients.

162 The mortality rate in patients with IC and a BDG concentrati

163 The mortality rate in patients without IC but a BDG concentr

164 clinical features of dengue-HLH, (3) assess mortality rate in SD and dengue-HLH, and (4) identify mo

165 (AAA) is a severe aortic disease with a high mortality rate in the event of rupture.

166 uced the clinical signs of infection and the mortality rate in the experimental group E2 receiving Au

167 nd decreased by 6.45% in Sub-Saharan Africa; mortality rates in 2015 were observed as 27.9 per 100,00

168 ngly, this subgroup had significantly higher mortality rates in all three etiologies of illness (0% v

169 is associated with significant morbidity and mortality rates in both adults and children, and emphasi

170 broad application of testing leads to lower mortality rates in countries like Germany or South Korea

171 dramatically increased disease severity and mortality rates in humans and gnotobiotic piglets.

172 Age-standardized mortality rates in Italy showed favorable patterns over

173 Overall mortality rates in LICs (13.3 deaths per 1000 person-yea

174 was to examine whether elevated in-hospital mortality rates in lower volume hospitals are only valid

175 , gut bacteria-associated sepsis caused high mortality rates in mice exposed to 6-9 Gy of gamma-rays.

176 The mortality rates in patients with repetitive bleeding, re

177 The higher mortality rates in people with severe mental illness (SM

178 Despite the decreasing mortality rates in recent years, the Whipple procedure i

179 a 20-30% increase in total ETEC and shigella mortality rates in some subnational areas.

180 n recovered production performance and lower mortality rates in the experimental group E2.

181 lps us understand the striking morbidity and mortality rates in the field, as well as the rapidly exp

182 Ninety-day mortality rates in the groups with and without ITBA were

183 s the COVID-19 per capita overall and excess mortality rates in the US vs that of 18 OECD countries a

184 matic brain injury mice (TBI + Sp) had a 25% mortality rate, in contrast to no mortality in S. pneumo

185 Mortality rates increased from cooler-wetter to warmer-d

186 ating disease of premature infants with high mortality rate, indicating the need for precision treatm

187 ems to evaluate patient-level data including mortality rates, intensive care unit bed days, and venti

188 The heart disease-specific mortality rate is 10.61/10,000-person years, and the sta

189 High quality of care, with in-hospital mortality rates less or equal to high-volume hospitals,

190 Regional variations in maternal mortality rates may relate to the availability of birth-

191 nosis and treatment have led to a decline in mortality rates, morbidity rates have remained relativel

192 asured by stillbirth rate [SBR] and neonatal mortality rate [NMR]) and mean time taken to complete th

193 we observed racial variation in age-specific mortality rates not fully captured with examination of a

194 h COVID-19 and is associated with a hospital mortality rate of >60%.

195 6 per 1000 person-years and a liver-specific mortality rate of 11.77 per 1000 person-years.

196 tory subtype of NAFLD, with annual all-cause mortality rate of 25.56 per 1000 person-years and a live

197 omised individuals, as reflected by the high mortality rate of 33 to 46% and the low 5-year survival

198 (11.5% of MaSBO population) had a predicted mortality rate of 39.4%.

199 n's mortality risk with the age-standardized mortality rate of adults.

200 Anorexia nervosa has the highest mortality rate of any psychiatric condition, yet the pat

201 eltiae (SF-MOR9 or SF-MOR10) caused a higher mortality rate of C. capitata larvae.

202 The high mortality rate of CCA is a consequence of delayed diagno

203 try, directly age-standardised incidence and mortality rate of cervical cancer, indirectly standardis

204 e most affected region in Italy: the current mortality rate of COVID-19 patients is 18.3% (10 022 dea

205 Given the high associated mortality rate of over 50% for patients with esophagoper

206 in lung transplant recipients (LTRs) causes mortality rates of 10%-20% despite antiviral therapy.

207 ine-2 receptor blockers resulted in hospital mortality rates of 18.3% vs 17.5%, respectively, a diffe

208 C. difficile infections have mortality rates of 6 to 30% and significantly increase h

209 Owing to the prevalence and high mortality rates of cardiac diseases, a more detailed cha

210 this study, we characterized low temperature mortality rates of H. halys adults that were either ente

211 The mortality rates of large trees are critical to determini

212 erienced its highest pertussis incidence and mortality rates of the last decade; 60% of deaths were a

213 uses significant disease in humans, carrying mortality rates of ~25%.

214 nd tagging experiments revealed similar kelp mortality rates on reefs dominated by healthy kelp fores

215 g viruses, can cause severe disease and high mortality rates on spillover into human populations.

216 otal mortality rate (as well as PCa specific mortality rate) on the percentage of (Gleason pattern-ba

217 and calculate its impact on overall neonatal mortality rate over a 12-year period (1998-2009).

218 creases in sepsis incidence and decreases in mortality rates over time.

219 rends in cardiovascular disease age-adjusted mortality rates overall and across subgroups stratified

220 ass index was the only factor increasing the mortality rate (p = 0.039).

221 For the 5-year mortality rate, PC1 did not contribute to an improvement

222 Mortality rates peaked 2 wk later, coinciding with a sec

223 Complication and mortality rates peaked in 1998 (11.7% and 1%) and progre

224 Neonatal mortality rate per 1000 live births was 11.4.

225 The Lotka-Volterra model with a fluctuating mortality rate predicts that this outcome is independent

226 current data indicate that the perioperative mortality rates range from 0.03% to 0.2%, which has subs

227 90sHR experienced lower health-related late mortality (rate ratio [95% CI]: 90sSR, 0.2 [0.1 to 0.4];

228 In relative terms, the mortality rate ratio (Russia/Norway) would decline from

229 Both later emergency declaration (adjusted mortality rate ratio [aMRR] 1.05 per day delay, 95% CI 1

230 rst year was higher among patients with ECI (mortality rate ratio [MRR] = 10.0; 95% confidence interv

231 and assessed in Cox models providing 6-week mortality rate ratios (MRRs) and hospitalization inciden

232 oodstream infection is the most severe, with mortality rates reaching 20 to 50%.

233 The mortality rate related to COVID-19 disease was 1% in the

234 lence of acute brain injury in recent years, mortality rates remain high when ischemic and hemorrhagi

235 advanced therapeutic options, morbidity and mortality rates remain high.

236 ed the largest reduction in particle-related mortality rates respectively.

237 s with 30-day RSRR, 30-day risk-standardized mortality rate (RSMR), and 1-year RSMR.

238 e same age, while women >=50 years old had a mortality rate similar to that of age-matched men, but c

239 African American (AA) patients have a higher mortality rate than European American (EA) patients.

240 reduced graft survival, recipients had lower mortality rates than those remaining on dialysis, even i

241 bacterial disease with high morbidity and a mortality rate that can be as high as 40% in resource-po

242 ks, COVID-19 infection has a relatively high mortality rate, the reasons for which are not entirely c

243 if increased size itself results in elevated mortality rates, then this could reduce by about half th

244 This mosquito species was resistant (30-63% mortality rate) to lambda-cyhalothrin.

245 64 days), child (age 1-4 years), and under-5 mortality rates (U5MRs) for each ethnic group within eac

246 We determined differences in mortality rates using <90% and <93% oxygen saturation (S

247 While tree mortality rates vary greatly Amazon-wide, on average tre

248 a median follow-up of 4.9 years, the overall mortality rate was 1.4% (n = 197) in the surgery group a

249 The in-hospital mortality rate was 10.0%, and at a median follow-up of 1

250 The 7-day mortality rate was 14.9%.CONCLUSIONGiven the deadly natu

251 At 6 months, the mortality rate was 19.0 deaths per 100 person-years for

252 The mortality rate was 2.7 times higher in the WHO-I and WHO

253 The age-standardized CVD mortality rate was 2.7/1000 person-years among both men

254 Mortality rate was 22.3% (n = 25); 72.3% (n = 81) were h

255 At 1 year, the mortality rate was 24%; relapses and reinfection were ra

256 The overall mortality rate was 38%; 53% and 31% in patients with and

257 15.9-18.7), whereas in public hospitals the mortality rate was 39.3% (95% CI, 35.5-43.3).Conclusions

258 Their proportion to the total neonatal mortality rate was 48.6%; out of 298 periviables 146 (43

259 Overall, the mortality rate was 5.8 per 1,000 person-years (or 831 de

260 The overall in-hospital mortality rate was 59.9%.

261 Mortality rate was 6.8/100 person-years (PYs) (95% CI 5.

262 The overall 30-day mortality rate was 60%; in contrast, 95% of ST16 cases w

263 The overall mortality rate was 7.2%, and nonfatal morbidities 22.2%.

264 bility of treatment weighting method, 28-day mortality rate was compared between the groups as well a

265 Consistent with late presentations, the mortality rate was high, whereas frequencies of LVRR and

266 The overall 30-day mortality rate was higher among patients with HCAI (9.6%

267 The mortality rate was lower in communities assigned to azit

268 including CD4 count, a substantially higher mortality rate was predicted among men <30 years old com

269 The mortality rate was reduced by the use of antifungal ther

270 Mortality rate was significantly higher among frail part

271 The 30-day mortality rate was significantly higher in dependent NIV

272 The mortality rate was significantly higher in patients with

273 The overall 30-day mortality rate was similar in both time periods (1.8% ve

274 ographic variability in age-standardized EGS mortality rates was also significant at the region level

275 morbidity, and the overall 30-day and 90-day mortality rates were 1.8% and 3.3%, respectively.

276 For MELD score 25, inpatient mortality rates were 11.2% (LA = 1 mmol/L), 19.4% (LA =

277 The 30-day and 1-year mortality rates were 13.2% and 22.9%, respectively, and

278 In-ICU and 6-month postadmission mortality rates were 17% and 22%, respectively.

279 am infections (n=319) overall 30- and 90-day mortality rates were 27% and 38%, respectively.

280 Crude and age-standardized cumulative mortality rates were 29.6% versus 19.9%, respectively, a

281 Mortality rates were 9.4% (27/286) overall, 16.5% (27/16

282 Thirty-day all-cause mortality rates were 9.7% and 12.8% in the exebacase + a

283 Importantly, in-hospital mortality rates were almost 385-fold higher among those

284 Age-standardized incidence and mortality rates were calculated by sex, country, and lev

285 Adjusted state-specific hemodialysis mortality rates were determined in 3-year intervals amon

286 Mortality rates were higher in SIGa-Bage.

287 Although mortality rates were higher in the underweight subgroups

288 Adjusted mortality rates were highly spatially correlated, repres

289 The highest mortality rates were observed for patterns that included

290 Lowest adjusted mortality rates were observed in highest volume quintile

291 hospital characteristics, complications and mortality rates were obtained.

292 pared to women in the same age groups, men's mortality rates were particularly elevated among those <

293 Mortality rates were similar, but in the HLA-ID group, 1

294 lity (n = 1,581 individuals), and intraguild mortality rates were superadditive, increasing from 10.6

295 can cause life-threatening illness with high mortality rates, which increase with delays in antimicro

296 h, life-long reproduction and no increase in mortality rate with age.

297 eatment options contribute to high morbidity/mortality rates with carbapenem-resistant, Gram-negative

298 Mortality rates with hazard ratios (HR) and 95% CI were

299 n alphacoronavirus that causes a nearly 100% mortality rate without effective treatment.

300 ced somatic state indicated by the increased mortality rate would result in lower reproductive output